Researchers examined the long-term natural history of branch-duct intraductal papillary mucinous neoplasms and sought to identify clinical and radiologic factors linked to developing pancreatic cancer ...

Association of hypophosphatemia-occurring sorafenib with prognosis and hepatic impairment in patients with advanced hepatocellular carcinoma. Background: Intraductal papillary mucinous neoplasm (IPMN) ...

How Do Precancerous Lesions Develop Towards Pancreatic Cancer? Pancreatic cancer is one of the deadliest diseases in United States, with a 5-year survival of 12% and is considered to be one of the ...

A research team at Duke Health has identified a set of biomarkers that could help to distinguish whether cysts on the pancreas are likely to develop into cancer or remain benign. The team carried out ...

All cases of IPMT, diagnosed in our institution between March 1995 and June 2004, were analyzed. According to the preoperative localization of the IPMT, different types of pancreatic resection were ...

(SALT LAKE CITY)—Cancer of the pancreas is usually not detected until it's too late to cure. But precursor lesions that form in the pancreas and its ducts can signal the disease before it strikes, and ...

Researchers have outlined the comprehensive immune landscape and microbiome of pancreatic cysts as they progress from benign cysts to pancreatic cancer. The findings could reveal the mechanism of ...

Scientists have connected the dots between bacteria in the digestive system and an increased risk of malignant pancreatic tumors. The results of the study, featured in Gut Microbes, illuminates ...

Intraductal papillary mucinous neoplasms of the pancreas (IPMNs) are increasingly recognized in clinical practice. They are a unique clinicopathologic entity that is characterized by mucin production, ...